Mounjaro®
Starting from £179.99/mo
Start journey Learn moreInjecting half a dose of Wegovy is not something the pen is designed to do. Each Wegovy pre-filled pen delivers one complete, fixed dose — there is no mechanism to stop partway through or dial down the volume. If you are finding your current dose difficult to tolerate, that is a conversation to have with your prescriber before you reach for the pen, not a problem to solve by experimenting mid-injection. Wegovy is a prescription-only medicine, and every dose decision sits with the clinician who knows your full picture.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
You have moved up to the next strength, and the nausea is louder than you expected. Maybe it landed on a particularly inconvenient week (a holiday, a run of early starts) and you are wondering whether injecting half of it would take the edge off. It is a logical thought. The problem is that Wegovy's pre-filled pen does not work that way.
The pen is factory-set to release a single, complete volume of solution. There is no dose dial, no halfway click, no mechanism that lets you pause the plunger at 50%. Stopping the injection early (withdrawing the needle before the pen has completed its cycle) does not reliably deliver half the dose; it produces an unknown, uncontrolled amount. You lose the predictability that the titration schedule is built around, and you introduce a variable your prescriber has no way to account for.
The licensed Wegovy dose schedule is structured precisely because tolerability varies. The steps are close enough together that your body adjusts incrementally. That architecture is the tool for managing side effects, not the syringe itself. For a plain overview of how the pen works in practice, the NHS semaglutide medicines page is a clear starting point.
Wegovy is supplied as a pre-filled, single-use injection pen. Each pen contains one dose at one fixed concentration. When you press the injection button, a spring mechanism drives the plunger and the full contents are expelled into the subcutaneous tissue. The pen then locks, it cannot be reused or partially discharged on a second occasion.
Some patients search for information about Wegovy pen half-dose techniques after seeing posts on forums or social media. The reality is that no clinically validated partial-dose method exists for these pens. A short withdrawal mid-injection leaves drug in the needle hub, wastes medicine that has already left the cartridge, and gives you no reliable information about how much actually entered your tissue.
The 0.25 mg starting pen exists because Novo Nordisk built the lowest tolerable amount into the first step, and if you want a full walkthrough of using it correctly, our guide to injecting the Wegovy 0.25 mg pen takes you through the process step by step. That is the closest thing to a reduced dose that the system formally allows, and you can find further detail on what that introductory strength involves on our Wegovy 0.25 mg page. If you are on a higher step and struggling, your prescriber can formally move you back down; that is a legitimate clinical choice, not a workaround.
Side effects from semaglutide are most common in the first days after a new dose, and they are predominantly gastrointestinal, nausea, loose stools, fatigue, sometimes a heavy or bloated feeling. For most people they settle within one to two weeks as the body adjusts. Eating smaller meals, staying well hydrated, and avoiding fatty foods during that window all make a genuine difference.
If they do not settle, or if they are severe, the right move is to contact your prescriber. A clinician can formally delay your next titration step, hold you at your current dose for an additional four weeks, or step you back down to the previous strength. These are built-in options in the prescribing guidance, not exceptions. Trying to manage tolerability by guessing at a partial dose bypasses that safety net entirely.
The NHS England guidance on weight-management injections is clear that clinical oversight throughout treatment (including dose changes) is part of how these medicines are used safely. A question our prescribers hear regularly is whether a bad week justifies changing the dose; the answer is always: tell us, and we will work it out together.
If you are considering what Wegovy treatment looks like from the beginning, the Wegovy overview covers eligibility, how the titration works, and what to expect at each stage. For broader context on weight-loss treatment options, our treatment page sets out the full landscape.
Sometimes the half-dose question is not really about side effects. It is about making a pen last longer. Wegovy is not cheap, and stretching a pen across two weeks instead of one can feel like an obvious economy, particularly if a billing date falls awkwardly, or if you are waiting for pay day before placing the next order.
That reasoning is understandable, but it carries the same problem: uncontrolled delivery, unpredictable absorption, and a gap in your treatment record that your prescriber cannot see. Skipping or stretching doses also risks losing the appetite-suppressing effect that the consistent weekly schedule maintains.
If cost is a genuine concern, the better conversation is with your provider about timing orders, pausing treatment formally, or understanding exactly what your single monthly price covers. At nume, one price includes the consultation, the prescription, delivery, and aftercare, no subscriptions, no automatic renewals. You can read more about how private treatment is priced on our Wegovy access page. If you have questions that are not answered there, our team is reachable via the contact page.
Ready to speak to a prescriber about dose, tolerability, or starting treatment? Start your free consultation and a GPhC-registered independent prescriber will review your answers the same day.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.